Life Science Robotics Market Size, Report by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Life Science Robotics Market

5.1. COVID-19 Landscape: Life Science Robotics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Life Science Robotics Market, By Product Type

8.1. Life Science Robotics Market Revenue and Volume Forecast, by Product Type

8.1.1. Laboratory Automation Robots

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Analytical & Testing Robots

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Bioprocessing & Cell Culture Robots

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. AI-Integrated Robotics Platforms

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Disinfection & Sterilization Robots

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Ancillary Robotic Tools & Accessories

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global Life Science Robotics Market, By Deployment Type

9.1. Life Science Robotics Market Revenue and Volume Forecast, by Deployment Type

9.1.1. On-Premise

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cloud-Based

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Hybrid Deployment

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Life Science Robotics Market, By Application

10.1. Life Science Robotics Market Revenue and Volume Forecast, by Application

10.1.1. Drug Discovery & Development

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Genomics & Proteomics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Clinical Diagnostics & Lab Automation

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Cell Therapy & Regenerative Medicine

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Other Applications

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Life Science Robotics Market, By Technology/Mode of Action

11.1. Life Science Robotics Market Revenue and Volume Forecast, by Technology/Mode of Action

11.1.1. Robotic Process Automation (RPA)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. AI & Machine Learning-Driven Robotics

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Vision-Guided Robotics Systems

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Collaborative Robotics (Cobots)

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Other Robotics Technologies

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Life Science Robotics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Deployment Type

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Deployment Type

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Deployment Type

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Deployment Type

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Deployment Type

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Deployment Type

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Deployment Type

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Deployment Type

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Deployment Type

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Deployment Type

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Deployment Type

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Deployment Type

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Deployment Type

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Deployment Type

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Deployment Type

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Deployment Type

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by Technology/Mode of Action

Chapter 13. Company Profiles

13.1. Danaher Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Becton, Dickinson and Company (BD)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Roche Diagnostics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. Siemens Healthineers

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Abbott Laboratories

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Qiagen

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. Hudson Robotics

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Kawasaki Robotics

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Yaskawa Electric Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. ABB Robotics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the life science robotics market include Danaher Corporation, Becton, Dickinson and Company (BD), Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Hudson Robotics, Kawasaki Robotics, Yaskawa Electric Corporation, ABB Robotics, Siemens Digital Industries, SPT Labtech, Biosero, and Automata Tech.

The driving factors of the life science robotics market are the rising research & development investments, which support the development of more advanced and precise robotic systems. Concurrently, the increasing demand for healthcare services, driven by an aging global population, is contributing to market growth.

North America region will lead the global life science robotics market during the forecast period 2026 to 2035.